|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/50 | |
| A61P 43/00 |
| (11) | Patento numeris | 3193942 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15756512.8 |
| Europos patento paraiškos padavimo data | 2015-08-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/044718 |
| Data | 2015-08-11 |
| (87) | Numeris | WO 2016/025523 |
| Data | 2016-02-18 |
| (30) | Numeris | Data | Šalis |
| 201462036084 P | 2014-08-11 | US |
| (72) |
CONCINO, Michael F., US
STRACK-LOGUE, Bettina, US
MEIYAPPAN, Muthuraman, US
NORTON, Angela W., US
ZHANG, Bohong, US
ISKENDERIAN, Andrea, US
FENG, Jianwen, US
HOLMES, Kevin, US
PAN, Jing, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington, MA 02421,
US
|
| (54) | LYSOSOMAL TARGETING AND USES THEREOF |
| LYSOSOMAL TARGETING AND USES THEREOF |